Sphingosine analog fingolimod (FTY720) increases radiation sensitivity of human breast cancer cells in vitro

References

• Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893 - 917; http://dx.doi.org/10.1002/ijc.25516; PMID: 21351269
   PubMed Web of Science ®Google Scholar
• Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010; 60:277 - 300; http://dx.doi.org/10.3322/caac.20073; PMID: 20610543
   PubMed Web of Science ®Google Scholar
• Kols A. Breast cancer: increasing incidence. Limited Options. Outlook 2002; 19:1 - 8
   Google Scholar
• Jung S, Lee S, Lee J, Li C, Ohk JY, Jeong HK, Lee S, Kim S, Choi Y, Kim S, et al. Protein expression pattern in response to ionizing radiation in MCF-7 human breast cancer cells. Oncol Lett 2012; 3:147 - 54; PMID: 22740871
   PubMed Web of Science ®Google Scholar
• Tassone P, Tagliaferri P, Perricelli A, Blotta S, Quaresima B, Martelli ML, Goel A, Barbieri V, Costanzo F, Boland CR, et al. BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer 2003; 88:1285 - 91; http://dx.doi.org/10.1038/sj.bjc.6600859; PMID: 12698198
   PubMed Web of Science ®Google Scholar
• Baran Y, Salas A, Senkal CE, Gunduz U, Bielawski J, Obeid LM, Ogretmen B. Alterations of ceramide/sphingosine 1-phosphate rheostat involved in the regulation of resistance to imatinib-induced apoptosis in K562 human chronic myeloid leukemia cells. J Biol Chem 2007; 282:10922 - 34; http://dx.doi.org/10.1074/jbc.M610157200; PMID: 17303574
   PubMed Web of Science ®Google Scholar
• Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim Biophys Acta 2002; 1585:193 - 201; http://dx.doi.org/10.1016/S1388-1981(02)00341-4; PMID: 12531554
   PubMed Web of Science ®Google Scholar
• Taha TA, Kitatani K, El-Alwani M, Bielawski J, Hannun YA, Obeid LM. Loss of sphingosine kinase-1 activates the intrinsic pathway of programmed cell death: modulation of sphingolipid levels and the induction of apoptosis. FASEB J 2006; 20:482 - 4; PMID: 16507765
   PubMedGoogle Scholar
• Pchejetski D, Golzio M, Bonhoure E, Calvet C, Doumerc N, Garcia V, Mazerolles C, Rischmann P, Teissié J, Malavaud B, et al. Sphingosine kinase-1 as a chemotherapy sensor in prostate adenocarcinoma cell and mouse models. Cancer Res 2005; 65:11667 - 75; http://dx.doi.org/10.1158/0008-5472.CAN-05-2702; PMID: 16357178
   PubMed Web of Science ®Google Scholar
• Chiba K. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. Pharmacol Ther 2005; 108:308 - 19; http://dx.doi.org/10.1016/j.pharmthera.2005.05.002; PMID: 15951022
   PubMed Web of Science ®Google Scholar
• Kappos L, Antel J, Comi G, Montalban X, O’Connor P, Polman CH, Haas T, Korn AA, Karlsson G, Radue EW, FTY720 D2201 Study Group. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med 2006; 355:1124 - 40; http://dx.doi.org/10.1056/NEJMoa052643; PMID: 16971719
   PubMed Web of Science ®Google Scholar
• Yasui H, Hideshima T, Raje N, Roccaro AM, Shiraishi N, Kumar S, Hamasaki M, Ishitsuka K, Tai YT, Podar K, et al. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance. Cancer Res 2005; 65:7478 - 84; http://dx.doi.org/10.1158/0008-5472.CAN-05-0850; PMID: 16103102
   PubMed Web of Science ®Google Scholar
• Wang JD, Takahara S, Nonomura N, Ichimaru N, Toki K, Azuma H, Matsumiya K, Okuyama A, Suzuki S. Early induction of apoptosis in androgen-independent prostate cancer cell line by FTY720 requires caspase-3 activation. Prostate 1999; 40:50 - 5; http://dx.doi.org/10.1002/(SICI)1097-0045(19990615)40:1<50::AID-PROS6>3.0.CO;2-N; PMID: 10344723
   PubMed Web of Science ®Google Scholar
• Azuma H, Horie S, Muto S, Otsuki Y, Matsumoto K, Morimoto J, Gotoh R, Okuyama A, Suzuki S, Katsuoka Y, et al. Selective cancer cell apoptosis induced by FTY720; evidence for a Bcl-dependent pathway and impairment in ERK activity. Anticancer Res 2003; 23:3183 - 93; PMID: 12926052
   PubMed Web of Science ®Google Scholar
• Ubai T, Azuma H, Kotake Y, Inamoto T, Takahara K, Ito Y, Kiyama S, Sakamoto T, Horie S, Muto S, et al. FTY720 induced Bcl-associated and Fas-independent apoptosis in human renal cancer cells in vitro and significantly reduced in vivo tumor growth in mouse xenograft. Anticancer Res 2007; 27:1A 75 - 88; PMID: 17352219
   PubMedGoogle Scholar
• Tanaka T, Takahara S, Hatori M, Suzuki K, Wang J, Ichimaru N, Suzuki S, Morozumi K, Okuyama A, Yamanaka H. A novel immunosuppressive drug, FTY720, prevents the cancer progression induced by cyclosporine. Cancer Lett 2002; 181:165 - 71; http://dx.doi.org/10.1016/S0304-3835(01)00799-6; PMID: 12175531
   PubMed Web of Science ®Google Scholar
• Jin S, White E. Tumor suppression by autophagy through the management of metabolic stress. Autophagy 2008; 4:563 - 6; PMID: 18326941
   PubMed Web of Science ®Google Scholar
• Cutuli B. [Radiotherapy for breast cancer: which strategy in 2012?]. Cancer Radiother 2012; 16:493 - 502; http://dx.doi.org/10.1016/j.canrad.2012.07.185; PMID: 22925489
   PubMed Web of Science ®Google Scholar
• Begg AC, Stewart FA, Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 2011; 11:239 - 53; http://dx.doi.org/10.1038/nrc3007; PMID: 21430696
   PubMed Web of Science ®Google Scholar
• Takabe K, Paugh SW, Milstien S, Spiegel S. “Inside-out” signaling of sphingosine-1-phosphate: therapeutic targets. Pharmacol Rev 2008; 60:181 - 95; http://dx.doi.org/10.1124/pr.107.07113; PMID: 18552276
   PubMed Web of Science ®Google Scholar
• Pyne S, Bittman R, Pyne NJ. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res 2011; 71:6576 - 82; http://dx.doi.org/10.1158/0008-5472.CAN-11-2364; PMID: 21940750
   PubMed Web of Science ®Google Scholar
• Ruckhäberle E, Rody A, Engels K, Gaetje R, von Minckwitz G, Schiffmann S, Grösch S, Geisslinger G, Holtrich U, Karn T, et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res Treat 2008; 112:41 - 52; http://dx.doi.org/10.1007/s10549-007-9836-9; PMID: 18058224
   PubMed Web of Science ®Google Scholar
• Guan H, Song L, Cai J, Huang Y, Wu J, Yuan J, Li J, Li M. Sphingosine kinase 1 regulates the Akt/FOXO3a/Bim pathway and contributes to apoptosis resistance in glioma cells. PLoS One 2011; 6:e19946; http://dx.doi.org/10.1371/journal.pone.0019946; PMID: 21625639
   PubMedGoogle Scholar
• Shida D, Takabe K, Kapitonov D, Milstien S, Spiegel S. Targeting SphK1 as a new strategy against cancer. Curr Drug Targets 2008; 9:662 - 73; http://dx.doi.org/10.2174/138945008785132402; PMID: 18691013
   PubMed Web of Science ®Google Scholar
• Stevenson CE, Takabe K, Nagahashi M, Milstien S, Spiegel S. Targeting sphingosine-1-phosphate in hematologic malignancies. [Review] Anticancer Agents Med Chem 2011; 11:794 - 8; http://dx.doi.org/10.2174/187152011797655122; PMID: 21707492
   PubMed Web of Science ®Google Scholar
• Chautard E, Loubeau G, Tchirkov A, Chassagne J, Vermot-Desroches C, Morel L, Verrelle P. Akt signaling pathway: a target for radiosensitizing human malignant glioma. Neuro Oncol 2010; 12:434 - 43; PMID: 20406894
   PubMed Web of Science ®Google Scholar
• Toker A, Yoeli-Lerner M. Akt signaling and cancer: surviving but not moving on. [Review] Cancer Res 2006; 66:3963 - 6; http://dx.doi.org/10.1158/0008-5472.CAN-06-0743; PMID: 16618711
   PubMed Web of Science ®Google Scholar
• Rödel F, Hoffmann J, Distel L, Herrmann M, Noisternig T, Papadopoulos T, Sauer R, Rödel C. Survivin as a radioresistance factor, and prognostic and therapeutic target for radiotherapy in rectal cancer. Cancer Res 2005; 65:4881 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-04-3028; PMID: 15930309
   PubMed Web of Science ®Google Scholar
• Asanuma K, Kobayashi D, Furuya D, Tsuji N, Yagihashi A, Watanabe N. A role for survivin in radioresistance of pancreatic cancer cells. Jpn J Cancer Res 2002; 93:1057 - 62; http://dx.doi.org/10.1111/j.1349-7006.2002.tb02483.x; PMID: 12359060
   PubMedGoogle Scholar
• Shen S, Kepp O, Kroemer G. The end of autophagic cell death?. Autophagy 2012; 8:1 - 3; http://dx.doi.org/10.4161/auto.8.1.16618; PMID: 22082964
   PubMed Web of Science ®Google Scholar
• Zhang N, Qi Y, Wadham C, Wang L, Warren A, Di W, Xia P. FTY720 induces necrotic cell death and autophagy in ovarian cancer cells: a protective role of autophagy. Autophagy 2010; 6:1157 - 67; http://dx.doi.org/10.4161/auto.6.8.13614; PMID: 20935520
   PubMed Web of Science ®Google Scholar
• Wallington-Beddoe CT, Hewson J, Bradstock KF, Bendall LJ. FTY720 produces caspase-independent cell death of acute lymphoblastic leukemia cells. Autophagy 2011; 7:707 - 15; http://dx.doi.org/10.4161/auto.7.7.15154; PMID: 21460633
   PubMed Web of Science ®Google Scholar
• Liao AJ, Hu R, Li YC, Yao K, Wang HH, Zhang R, Yang W, Liu ZG. [The study of FTY720 on inducing apoptosis and autophagy in multiple myeloma cell line U266]. Zhonghua Xue Ye Xue Za Zhi 2011; 32:664 - 7; PMID: 22339823
   PubMedGoogle Scholar
• Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K, Zhang R, Wang H, Yang W, Liu Z. Autophagy induced by FTY720 promotes apoptosis in U266 cells. Eur J Pharm Sci 2012; 45:600 - 5; http://dx.doi.org/10.1016/j.ejps.2011.12.014; PMID: 22281442
   PubMed Web of Science ®Google Scholar
• Young MM, Kester M, Wang HG. Sphingolipids: regulators of crosstalk between apoptosis and autophagy. J Lipid Res 2013; 54:5 - 19; http://dx.doi.org/10.1194/jlr.R031278; PMID: 23152582
   PubMed Web of Science ®Google Scholar
• Klionsky DJ, Emr SD. Autophagy as a regulated pathway of cellular degradation. Science 2000; 290:1717 - 21; http://dx.doi.org/10.1126/science.290.5497.1717; PMID: 11099404
   PubMed Web of Science ®Google Scholar
• Meijer AJ, Codogno P. Regulation and role of autophagy in mammalian cells. Int J Biochem Cell Biol 2004; 36:2445 - 62; http://dx.doi.org/10.1016/j.biocel.2004.02.002; PMID: 15325584
   PubMed Web of Science ®Google Scholar
• Qu X, Zou Z, Sun Q, Luby-Phelps K, Cheng P, Hogan RN, Gilpin C, Levine B. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 2007; 128:931 - 46; http://dx.doi.org/10.1016/j.cell.2006.12.044; PMID: 17350577
   PubMed Web of Science ®Google Scholar
• Tassone P, Blotta S, Palmieri C, Masciari S, Quaresima B, Montagna M, D’Andrea E, Eramo OP, Migale L, Costanzo F, et al. Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents. Int J Oncol 2005; 26:1257 - 63; PMID: 15809716
   PubMed Web of Science ®Google Scholar
• Marvaso G, Barone A, Vaccaro C, Bruzzaniti V, Grespi S, Scotti V, Bianco C. Repeat stereotactic radiosurgery in the management of brain metastases from NSCLC: A case report and review of the literature. Oncol Lett 2013; 6:897 - 900; PMID: 24137433
   PubMed Web of Science ®Google Scholar
• Amodio N, Di Martino MT, Foresta U, Leone E, Lionetti M, Leotta M, Gullà AM, Pitari MR, Conforti F, Rossi M, et al. miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis 2012; 3:e436; http://dx.doi.org/10.1038/cddis.2012.175; PMID: 23190608
   PubMed Web of Science ®Google Scholar
• Tagliaferri P, Katsaros D, Clair T, Neckers L, Robins RK, Cho-Chung YS. Reverse transformation of Harvey murine sarcoma virus-transformed NIH/3T3 cells by site-selective cyclic AMP analogs. J Biol Chem 1988; 263:409 - 16; PMID: 2826444
   PubMed Web of Science ®Google Scholar
• Amodio N, Leotta M, Bellizzi D, Di Martino MT, D’Aquila P, Lionetti M, Fabiani F, Leone E, Gullà AM, Passarino G, et al. DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma. Oncotarget 2012; 3:1246 - 58; PMID: 23100393
   PubMed Web of Science ®Google Scholar
• Amodio N, Scrima M, Palaia L, Salman AN, Quintiero A, Franco R, Botti G, Pirozzi P, Rocco G, De Rosa N, et al. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas. Am J Pathol 2010; 177:2622 - 34; http://dx.doi.org/10.2353/ajpath.2010.091075; PMID: 20889565
   PubMed Web of Science ®Google Scholar